Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24 Helena H. BorbaAstrid WiensRoberto Pontarolo Review 19 October 2016 Pages: 1 - 14
Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study P. GueretS. CombeE. Neuhart Clinical Trial 15 October 2016 Pages: 15 - 28
Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population Ya-li NieHang HeQuan-cheng Kan Pharmacogenetics 05 October 2016 Pages: 29 - 37
FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients Zhuo WuQinxia XuMingkang Zhong Pharmacogenetics 17 October 2016 Pages: 39 - 47
Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjects Poe-Hirr HsyuDaniela Soriano PignataroKyle Matschke Pharmacokinetics and Disposition 07 October 2016 Pages: 49 - 56
Effect of bosutinib on the absorption of dabigatran etexilate mesylate, a P-glycoprotein substrate, in healthy subjects Poe-Hirr HsyuDaniela Soriano PignataroKyle Matschke Pharmacokinetics and Disposition 07 October 2016 Pages: 57 - 63
Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus A K Hemanth KumarV ChandrasekaranGeetha Ramachandran Pharmacokinetics and Disposition 20 September 2016 Pages: 65 - 70
A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis Daniel FB WrightMatthew P. DoogueLisa K Stamp Pharmacokinetics and Disposition 28 September 2016 Pages: 71 - 78
Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission Daniel Sevilla-SanchezNúria Molist-BrunetCarles Codina-Jané Pharmacoepidemiology and Prescription 04 October 2016 Pages: 79 - 89
Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence Lucie BlaisFatima-Zohra KettaniFrancine M. Ducharme Pharmacoepidemiology and Prescription 01 October 2016 Pages: 91 - 97
Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson’s disease François MontastrucFlorence MoulisJean-Louis Montastruc Pharmacoepidemiology and Prescription 27 October 2016 Pages: 99 - 103
Characteristics and drug use patterns of older antidepressant initiators in Germany Kathrin JobskiNiklas SchmedtEdeltraut Garbe Pharmacoepidemiology and Prescription 18 October 2016 Pages: 105 - 113
Evaluation of methods to estimate missing days’ supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN) Kirsten J. LumCraig W. NewcombVincent Lo Re III Pharmacoepidemiology and Prescription 27 October 2016 Pages: 115 - 123
Benefits of a national network of drug information centres: RELIS Jan Schjøtt Letter to the Editor Open access 15 September 2016 Pages: 125 - 126
Erratum to: Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol Lisbeth PatteetVincent HaufroidHugo Neels Erratum 13 October 2016 Pages: 127 - 127